THYMIC CARCINOMA
Clinical trials for THYMIC CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new THYMIC CARCINOMA trials appear
Sign up with your email to follow new studies for THYMIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug hope for rare thymus cancers after standard treatments fail
Disease control Recruiting nowThis study tests a drug called sacituzumab govitecan in adults with advanced thymoma or thymic carcinoma that has worsened after at least one prior treatment. Participants receive the drug intravenously once weekly for two weeks, then a week off, and continue until the cancer pro…
Matched conditions: THYMIC CARCINOMA
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated May 17, 2026 04:33 UTC
-
New combo therapy offers hope for rare thymus cancers after first-line failure
Disease control Recruiting nowThis study tests a combination of two drugs, tislelizumab and anlotinib, in 20 people with thymoma or thymic carcinoma whose cancer worsened after initial chemotherapy (with or without immunotherapy). The goal is to see if this second-line treatment can shrink or control tumors. …
Matched conditions: THYMIC CARCINOMA
Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated May 17, 2026 04:30 UTC
-
Engineered immune cells take on Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage study tests a new treatment called CD70-targeted CAR-T cells in people with advanced solid tumors, including kidney, lung, and ovarian cancers. The therapy uses a patient's own immune cells, modified to recognize and attack cancer cells that have a specific marke…
Matched conditions: THYMIC CARCINOMA
Phase: PHASE1 • Sponsor: Chongqing Precision Biotech Co., Ltd • Aim: Disease control
Last updated May 17, 2026 04:14 UTC
-
New combo therapy shows promise for rare chest cancer
Disease control Recruiting nowThis study tests whether combining the drug envolizumab with radiation therapy before surgery can shrink tumors in people with locally advanced thymic carcinoma, a rare chest cancer. About 25 adults aged 18-75 will receive the combination treatment, then have surgery to remove an…
Matched conditions: THYMIC CARCINOMA
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New trial tests if adding chemo to radiation stops thymic cancer from coming back
Disease control Recruiting nowThis study looks at whether adding chemotherapy to standard radiation therapy helps prevent thymic cancer from returning after surgery. About 172 adults who had their thymic cancer completely removed will receive either radiation alone or radiation plus four cycles of chemotherap…
Matched conditions: THYMIC CARCINOMA
Phase: PHASE3 • Sponsor: Fudan University • Aim: Disease control
Last updated May 12, 2026 13:40 UTC